Effect of prior cancer on survival outcomes for patients with advanced prostate cancer

被引：0
|
作者：
Yechen Wu
Xi Chen
Duocheng Qian
Wei Wang
Yiping Zhang
Jinxin Hu
Jun Zhu
Qiang Wu
Tinghu Cao
机构：
[1] Baoshan Branch,Department of Urology
[2] Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Department of Urology
[3] Tongji Hospital,Department of Urology
[4] Tongji University School of Medicine,Department of Urology
[5] Shanghai Forth People’s Hospital Affiliated to Tongji University School of Medicine,undefined
[6] Tongji Hospital,undefined
[7] Tongji University School of Medicine,undefined
来源：
BMC Urology | / 21卷
关键词：
Advanced prostate cancer; Prior cancer; Survival; SEER; Trial eligibility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Surgical and survival outcomes of advanced epithelial ovarian cancer
    Manie, Tamer Mostafa
    Shokralla, Hala Aziz
    Sheier, Sayed Shaker
    Fathalla, Ahmed El-Sayed
    MEDICAL SCIENCE, 2021, 25 (116) : 2477 - 2490
  • [32] Prior cancer history predicts the worse survival of patients with nasopharyngeal carcinoma
    Yeh, Chien-Fu
    Chin, Yu-Ching
    Huang, Wei-Hao
    Lan, Ming-Ying
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (11) : 5381 - 5387
  • [33] Survival of Patients with Prostate Cancer in Yazd, Iran
    Zahir, Shokouh Taghipour
    Nazemian, Mohammad Reza
    Zand, Sanaz
    Zare, Samad
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (02) : 883 - 886
  • [34] Opioid Requirement, Opioid Receptor Expression, and Clinical Outcomes in Patients With Advanced Prostate Cancer
    Zylla, Dylan
    Gourley, Brett L.
    Vang, Derek
    Jackson, Scott
    Boatman, Sonja
    Lindgren, Bruce
    Kuskowski, Michael A.
    Le, Chap
    Gupta, Kalpna
    Gupta, Pankaj
    CANCER, 2013, 119 (23) : 4103 - 4110
  • [35] Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer
    McCormick, Barrett Z.
    Chery, Lisly
    Chapin, Brian F.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (05) : 2178 - 2187
  • [36] The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy
    Etheridge, Tyler
    Liou, Jinning
    Downs, Tracy M.
    Abel, E. Jason
    Richards, Kyle A.
    Jarrard, David F.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2018, 6 (03): : 123 - 132
  • [37] Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer
    Zhou, Yuan
    Lin, Changming
    Zhu, Lian
    Zhang, Rentao
    Cheng, Lei
    Chang, Yuanyuan
    CANCER MEDICINE, 2023, 12 (03): : 2600 - 2613
  • [38] Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Mejia, Alex
    Brenner, Andrew
    Sarantopoulos, John
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : 359 - 365
  • [39] Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual
    Wang, Ya-Qin
    Lv, Jia-Wei
    Tang, Ling-Long
    Du, Xiao-Jing
    Chen, Lei
    Li, Wen-Fei
    Liu, Xu
    Guo, Ying
    Lin, Ai-Hua
    Mao, Yan-Ping
    Sun, Ying
    Chen, Yu-Pei
    Ma, Jun
    ORAL ONCOLOGY, 2019, 90 : 23 - 29
  • [40] Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
    Gillessen, S.
    Omlin, A.
    Attard, G.
    de Bono, J. S.
    Efstathiou, E.
    Fizazi, K.
    Halabi, S.
    Nelson, P. S.
    Sartor, O.
    Smith, M. R.
    Soule, H. R.
    Akaza, H.
    Beer, T. M.
    Beltran, H.
    Chinnaiyan, A. M.
    Daugaard, G.
    Davis, I. D.
    De Santis, M.
    Drake, C. G.
    Eeles, R. A.
    Fanti, S.
    Gleave, M. E.
    Heidenreich, A.
    Hussain, M.
    James, N. D.
    Lecouvet, F. E.
    Logothetis, C. J.
    Mastris, K.
    Nilsson, S.
    Oh, W. K.
    Olmos, D.
    Padhani, A. R.
    Parker, C.
    Rubin, M. A.
    Schalken, J. A.
    Scher, H. I.
    Sella, A.
    Shore, N. D.
    Small, E. J.
    Sternberg, C. N.
    Suzuki, H.
    Sweeney, C. J.
    Tannock, I. F.
    Tombal, B.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1589 - 1604
12345